Trading Signals: ANPC Stock Price Prediction and Forecast (Thu. Jan. 30, 2020 - Fri. May. 13, 2022)(AnPac Bio-Medical Science Co Ltd - ADR)
| ANPC latest price $5.5900 (-7.91%) ($5.5900 - $6.2400) on Wed. Aug. 5, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.51% (three month average) | RSI | 55 | Latest Price | $5.5900(-7.91%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ANPC declines -5.1% a day on average for past five trading days. | Weekly Trend | ANPC advances 3.7% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ANPC advance at 0% a week (0% probability) XLB(11%) LIT(9%) IGOV(8%) PCY(8%) IPO(7%) | Factors Impacting ANPC price | ANPC will decline at least -3.255% in a week (0% probabilities). SHY(-20%) IBB(-10%) XBI(-9%) TBT(-7%) XLU(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.255% (StdDev 6.51%) | Hourly BBV | 0 () | Intraday Trend | -7.9% | | | |
|
Resistance Level | $5.67 | 5 Day Moving Average | $5.96(-6.21%) | 10 Day Moving Average | $5.86(-4.61%) | 20 Day Moving Average | $5.67(-1.41%) | To recent high | -32.6% | To recent low | 9.8% | Market Cap | $48m | | | | Anpac Bio-Medical Science Co. Ltd., is a biotechnology company. It engages in marketing and selling multi-cancer screening and detection test that uses patented cancer differentiation analysis, or CDA, technology and proprietary cancer-detection device or CDA device. The company was founded by Chris Chang Yu and He Yu in 2010 and is headquartered in Lishui, China. |